Hansa Biopharma AB (publ)
HNSBF News Today: Stay Updated with the Latest Hansa Biopharma AB (publ) News in Real Time
Find HNSBF news now at Meyka AI. Stay informed with the latest Hansa Biopharma AB (publ) stocks updates, including price news, market analysis, and expert insights.
BIOVF Earnings Beat: Swedish Orphan Biovitrum Tops EPS Estimates
Swedish Orphan Biovitrum (BIOVF) beat EPS estimates by 17.77% with $0.45 actual vs $0.38 expected. Revenue hit $755.76M.
BDNNY Boliden AB Earnings Beat EPS, Misses Revenue
Boliden AB (BDNNY) beat EPS estimates at $2.90 vs $2.86 expected, but missed revenue at $3.00B vs $3.01B forecast on April 28.
ASAZF ASSA ABLOY Earnings Miss: EPS Down 3.46%
ASSA ABLOY missed Q2 earnings with EPS of $0.3345 vs $0.3465 estimate and revenue of $3.76B vs $3.81B expected.
PKY.AX stock surges 26.8% on strong trading volume at ASX close
PKY.AX stock price hits A$0.052 with 26.8% gain and 70.8M volume. Pathkey.AI Ltd healthcare AI platform shows strong momentum on ASX.
CANF Director Tamir Ilan Files Initial Options Ownership, April 28, 2026
Can-Fite BioPharma director Tamir Ilan files initial ownership of 16,000 options at $2.25 per share on April 25, 2026.
EPIAF Earnings Preview: Epiroc AB (publ) Q2 2026 on April 29
Epiroc AB (EPIAF) reports Q2 2026 earnings April 29. Analysts expect $0.1930 EPS and $1.60B revenue. Meyka AI rates B+.
SVKEF Earnings Preview: SEB Reports April 29 Results
SEB earnings preview for April 29, 2026. Analysts expect $0.38 EPS and $1.96B revenue. Meyka AI rates SVKEF with B+ grade.
SWDBY Swedbank AB Earnings Preview April 29, 2026
Swedbank AB (SWDBY) reports Q1 2026 earnings April 29. Analysts expect $0.71 EPS and $1.82B revenue. Stock trades at $34.79.
GNGBY Getinge AB Earnings Miss Revenue Target by 3.76%
Getinge AB (GNGBY) missed Q1 2026 revenue estimate of $816.35M, reporting $785.68M. Stock up 1.69% post-earnings.